Fetal bovine serum (FBS) has long served as a foundational input for cell culture, tissue engineering, and biomanufacturing.

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

Summit has been a tremendous winner over the past year, as its bispecific antibody lung cancer drug ivonescimab outperformed ...

T he Forbes Midas List, now in its 24th year, continues to recognize the world’s top venture capitalists. This year’s list ...

PFS in Phase 3 HARMONi study was met with statistical significance, but OS was not. Click here to find out why SMMT stock is ...

Summit Therapeutics (NASDAQ:SMMT) lost ~29% on Friday, marking its second-biggest intraday decline this year after the Miami, ...

Mount Marty University will launch the region’s first Graduate Regulatory Science Program to train future leaders in the ...

This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...

Regneron stock crashed today following disappointing COPD trials data. Here's what makes REGN shares worth buying on the ...

Although the FDA has rejected Stealth’s new drug application for Barth syndrome candidate elamipretide, the agency identified ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Despite the long holiday weekend, news in biopharma never slows down. | This week on "The Top Line," we break down ...